Jennifer Jones-McMeans is Abbott's global clinical affairs leader. With over a decade of experience in medical devices and health care, Jennifer is an expert in clinical research and trial design strategy. She is crucial in getting approval for various medical devices in the U.S. and worldwide.
Jennifer has also been a vocal advocate for diversity and inclusion in clinical trials, striving for increased racial and gender equity among study participants. Jennifer promotes diversity and innovation in clinical trials to improve healthcare. She recognizes that the lack of diversity in clinical trials poses a significant risk to patient outcomes and is passionate about breaking down barriers to enrollment.
Jennifer has been instrumental in forming community partnerships and investing in training for underrepresented physicians to pursue clinical trial research and recruit participants from historically underrepresented groups.
She has led successful clinical trials focusing on improving hypertension among ethnic and indigent individuals and diversifying the LIFE-BTK trial, which studies severe diseases of the legs' arteries.
Her tireless efforts to promote diversity within clinical trials have earned her numerous awards, including the Silicon Valley Woman of Influence Award and Abbott's Chairman's Award. Her leadership in the LIFE-BTK ("below the knee") study has been a model for future studies and has received global recognition.
Abbott launched a new initiative in 2021 to drive diversity in medical research and improve care among underrepresented populations, which Jennifer supports. The company has dedicated $5 million to nearly 300 new scholarships over the next five years at medical schools at historically black colleges and universities through this initiative.
Abbott has also partnered with 'Women as One' to create training opportunities for physicians from underrepresented groups interested in leading clinical trials.
Jennifer's work aligns with Abbott's 2030 Sustainability Plan, which aims to improve the lives of more than three billion people by increasing access and affordability to life-changing technologies and products.
Abbott is working with other leaders in the field to break down the four main barriers to care and bring innovation to the people who need it most. Jennifer's work directly supports Abbott's sustainability goals, including achieving more significant representation of females in leadership and underrepresented groups within the organization. She also expanded the Abbott Family Science Program and promoted women's health education and screening.
Jennifer's tireless efforts make Abbott's work more inclusive and sustainable, resulting in a more equitable healthcare ecosystem. She holds a Ph.D. from the University of Maryland, College Park, an M.Sc. from California State University East Bay, and a B.A. from the University of San Francisco.